THE TGA has issued a recall order
for Aspen Pharma’s Serenace 0.5mg
tablets (containing haloperidol)
batch number BJ431.
The recall is being conducted
because the manufacturer has
received reports of tablets from
the affected batch with black spots
identified as penicillium species.
The order has been classified as
Class I meaning that the defects
are potentially life-threatening or
could cause a serious risk to health.
Patients are being advised not to
use the affected batch, but to
return it to their local pharmacy
and arrange for a replacement.The above article was sent to subscribers in Pharmacy Daily's issue from 19 Sep 12 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 19 Sep 12
MONTU Group, its subsidiary Alternaleaf Pty Ltd, and their common director Christopher Strauch are facing legal action by the Therapeutic Goods Administration (TGA) in the Federal Court of Australia for alleged unlawful advertising on the effectiveness of their medicinal cannabis products.
AUSTRALIA’S public hospitals are facing their lengthiest wait times on record for planned surgeries, with emergency departments struggling under access blockages, according to the latest annual Public Hospital Report Card by the Australian Medical Association (AMA).
THE University of South Australia has released a new study to help healthcare workers better support women with persistent pelvic pain, including symptoms that are suggestive of gynaecological, lower urinary tract, bowel, sexual, and pelvic floor dysfunction.
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.